My Angel's Migraine

Featured Article

Phase II study data on MK-0974, an investigational oral calcitonin gene-related peptide (CGRP) receptor antagonist showed:

  • MK-0974 significantly improved Migraine pain relief two hours after dosing (compared to placebo), and the relief was sustained through 24 hours.
  • MK-0974 was generally well tolerated.
  • In addition to pain relief, MK-0974 successfully relieved other Migraine symptoms including nausea, phonophobia (sensitivity to sound), and photophobia (sensitivity to light).

 
MK-0974 is...

Read more

More information on "My Angel's Migraine"

From Our Experts

See more SharePosts »

From Our Sources

More on Migraine »